BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Genetown

  Relay Therapeutics Lands $63M to Push Its Cancer Candidates Into Clinic

  The round was led by BVF Partners, with new investors GV, Casdin Capital, EcoR1 Capital and Section 32.

  December 14, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  It’s Official: Teva Cuts 14,000 Jobs in Massive Reorg

  Teva pulled the trigger on a comprehensive restructuring plan that includes the elimination of 25 percent of the company’s global workforce.

  December 14, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  Deals

  Another Biotech Bites the Dust as Cambridge’s Raze Shuts Down

  As part of a portfolio update, Altas Ventures noted that Raze Therapeutics, a biotech launched in 2014, has closed its doors.

  December 14, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Pharm Country

  Boulder Biotech Changes Name, Gives Away New CRISPR Enzyme -- Free of Charge

  In its announcement, Inscripta called the plan a “huge step forward for innovation” in the highly competitive gene-editing field.

  December 14, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  BioForest

  The Most Affordable CAR-T Biotech Stock Among Its Rivals Right Now

  Juno Therapeutics is now the “cheapest” player now developing CAR-T cancer medications, an analyst said Wednesday as he downgraded rival Bluebird Bio.

  December 14, 2017

   · 

  1 min read
• 

  Business

  These 2 Startups are Amgen’s 2017 Golden Ticket Winners

  Amgen tapped two companies to receive its coveted 2017 Golden Ticket at LabCentral.

  December 14, 2017

   · 

  3 min read

   · 

  Alex Keown
• Policy

  Medtronic Forks Over $12M to Settle Infuse False Marketing Claims

  The Mass. Attorney General said the deal will resolve an investigation by her office and those in four other states related to Medtronic’s promotion of Infuse.

  December 14, 2017

   · 

  1 min read
• Business

  BioVectra and Keryx Biopharma Enter Agreement for Ferric Citrate Production Expansion

  BioVectra today announced a long-term supply agreement with Keryx Biopharma to manufacture Ferric Citrate, the API in Auryxia tablets.

  December 14, 2017

   · 

  3 min read
• Drug Development

  BioSight Announces Phase I/II Results of its Cytarabine Pro-Drug BST-236 for Treatment of Acute Leukemia

  The results, presented at the 59th Annual ASH Meeting and Exposition by Dr. Tsila Zuckerman of the Rambam Healthcare Center, demonstrated safety and efficacy of BST-236 as a single agent in treatment of newly-diagnosed acute leukemia patients, unfit for standard induction therapy.

  December 14, 2017

   · 

  3 min read
• Pharm Country

  UCLA and Caltech Study Uses Technology Being Commercialized by IsoPlexis to Characterize Cancer Cells Resistant to Targeted Treatments

  The data helped researchers pinpoint the cellular characteristics and pathways that allow cancer cells to develop resistance to targeted therapies, and identify improved therapy combinations.

  December 14, 2017

   · 

  3 min read